Lenvatinib and Pembrolizumab
About
Membership operator: AND
Therapies: 2
Therapies
Lenvatinib (tx:ncit:C95124)
Pembrolizumab (tx:ncit:C106432)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | MSI-L | Endometrial Carcinoma | Lenvatinib, Pembrolizumab |